Loading...
XSHE
000004
Market cap206mUSD
Sep 30, Last price  
11.12CNY
Name

Shenzhen Cau Technology Co.

Chart & Performance

D1W1MN
P/E
—
P/S
14.92
EPS
—
Div Yield, %
—
Shrs. gr., 5y
9.53%
Rev. gr., 5y
-1.84%
Revenues
99m
-10.35%
61,376,72445,638,99740,449,54143,314,82460,080,600131,331,49474,503,71897,363,30172,784,56780,608,820120,454,422287,670,026138,605,841366,868,804108,246,697280,531,008288,944,181166,463,289110,048,54898,660,353
Net income
-132m
0619,804002,468,84511,624,0922,989,8912,005,25403,801,3731,247,11839,299,3108,566,7200064,623,126000-131,535,415
CFO
-17m
L-53.75%
11,060,815001,428,29846,596,046019,365,73917,562,720009,261,869147,929,75914,439,484003,973,9253,101,5310-36,050,911-16,671,888
Dividend
Jun 19, 20030.024 CNY/sh

Profile

Shenzhen GuoHua Network Security Technology Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells bio-pharmaceutical products in China. It offers products in the areas of cardiovascular, anti-infective, tumor immunity, nerve/analgesic, API, and gastrointestinal/reproductive. The company also provides clindamycin phosphate, adenosine triphosphate magnesium chloride, diisopropylamine dichloroacetate, cyclophosphamide, cytidine triphosphate disodium, urokinase, and other injection products. In addition, it engages in the development and sale of real estate properties, as well as housing property management activities. The company was formerly known as Shenzhen Cau Technology Co., Ltd and changed its name to Shenzhen GuoHua Network Security Technology Co., Ltd. in November 2020. Shenzhen GuoHua Network Security Technology Co., Ltd., was founded in 1990 and is based in Shenzhen, China.
URL
http://www.sz000004.cn
IPO date
Jan 14, 1991
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
98,660
-10.35%
110,049
-33.89%
166,463
-42.39%
Cost of revenue
134,231
109,548
194,765
Unusual Expense (Income)
NOPBT
(35,571)
501
(28,302)
NOPBT Margin
0.46%
Operating Taxes
(21,795)
(16,930)
Tax Rate
NOPAT
(13,776)
17,430
(28,302)
Net income
(131,535)
 
Dividends
Dividend yield
Proceeds from repurchase of equity
(935)
(33)
BB yield
0.00%
0.00%
Debt
Debt current
3,303
3,113
Long-term debt
12,503
14,555
11,416
Deferred revenue
472
472
Other long-term liabilities
25,768
15,340
4,786
Net debt
(67,622)
(89,996)
(115,173)
Cash flow
Cash from operating activities
(16,672)
(36,051)
CAPEX
(3,518)
(336)
Cash from investing activities
81
407
451
Cash from financing activities
(2,920)
(2,280)
FCF
47,965
118,027
87,490
Balance
Cash
72,254
93,706
129,091
Long term investments
11,174
10,845
610
Excess cash
78,495
99,048
121,378
Stockholders' equity
(1,156,211)
(1,035,255)
149,348
Invested Capital
1,264,918
1,251,741
199,388
ROIC
2.40%
ROCE
0.23%
EV
Common stock shares outstanding
132,383
132,651
146,354
Price
13.84
-14.20%
16.13
66.63%
9.68
-50.15%
Market cap
1,832,176
-14.37%
2,139,667
51.03%
1,416,706
-54.77%
EV
1,773,428
2,047,965
1,301,551
EBITDA
(27,513)
16,878
(12,969)
EV/EBITDA
121.34
Interest
703
714
315
Interest/NOPBT
142.52%